John G Ullman & Associates Inc Pfizer Inc Transaction History
John G Ullman & Associates Inc
- $624 Million
- Q2 2025
A detailed history of John G Ullman & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, John G Ullman & Associates Inc holds 150,703 shares of PFE stock, worth $3.73 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
150,703
Previous 261,167
42.3%
Holding current value
$3.73 Million
Previous $6.62 Million
44.79%
% of portfolio
0.59%
Previous 1.1%
Shares
32 transactions
Others Institutions Holding PFE
# of Institutions
3,347Shares Held
3.61BCall Options Held
104MPut Options Held
129M-
Vanguard Group Inc Valley Forge, PA523MShares$12.9 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.5 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$7.35 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$3.11 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.56 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $139B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...